{
    "ticker": "ZLAB",
    "name": "Zai Lab Limited",
    "description": "Zai Lab Limited is a biopharmaceutical company focused on discovering, developing, and commercializing innovative medicines. Established in 2014 and headquartered in Shanghai, China, Zai Lab aims to address significant unmet medical needs in oncology, autoimmune diseases, and infectious diseases with its robust pipeline of therapies. The company has established a strong presence in both China and the global market, leveraging strategic partnerships and collaborations to enhance its research and development capabilities. Zai Lab\u2019s lead products include several novel therapies, such as its immuno-oncology treatments and targeted therapies, which are designed to improve patient outcomes in various cancer types. In addition to its strong pipeline, Zai Lab is committed to advancing its scientific knowledge through clinical trials and collaborations with leading research institutions. With a mission to provide innovative and accessible healthcare solutions, Zai Lab is well-positioned to contribute to the future of medicine and improve the lives of patients around the world.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "Shanghai, China",
    "founded": "2014",
    "website": "https://www.zailaboratory.com",
    "ceo": "Dr. Samantha Du",
    "social_media": {
        "twitter": "https://twitter.com/ZaiLab",
        "linkedin": "https://www.linkedin.com/company/zai-lab-limited/"
    },
    "investor_relations": "https://investors.zailaboratory.com",
    "key_executives": [
        {
            "name": "Dr. Samantha Du",
            "position": "CEO"
        },
        {
            "name": "Dr. Yanzhong Chen",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Oncology",
            "products": [
                "ZL-2306",
                "ZL-1211"
            ]
        },
        {
            "category": "Autoimmune Diseases",
            "products": [
                "ZL-1103"
            ]
        }
    ],
    "seo": {
        "meta_title": "Zai Lab Limited | Innovating Healthcare Solutions",
        "meta_description": "Explore Zai Lab Limited, a biopharmaceutical company dedicated to developing innovative treatments for cancer and autoimmune diseases. Learn about Zai Lab's mission, pipeline, and impact.",
        "keywords": [
            "Zai Lab",
            "Biopharmaceuticals",
            "Oncology",
            "Autoimmune Diseases",
            "Innovative Medicines"
        ]
    },
    "faq": [
        {
            "question": "What does Zai Lab focus on?",
            "answer": "Zai Lab focuses on developing innovative medicines for oncology, autoimmune diseases, and infectious diseases."
        },
        {
            "question": "Who is the CEO of Zai Lab?",
            "answer": "Dr. Samantha Du is the CEO of Zai Lab Limited."
        },
        {
            "question": "Where is Zai Lab headquartered?",
            "answer": "Zai Lab is headquartered in Shanghai, China."
        },
        {
            "question": "What are Zai Lab's main products?",
            "answer": "Zai Lab's main products include therapies for oncology and autoimmune diseases, such as ZL-2306 and ZL-1103."
        },
        {
            "question": "When was Zai Lab founded?",
            "answer": "Zai Lab was founded in 2014."
        }
    ],
    "competitors": [
        "BMY",
        "GILD",
        "NVS",
        "AMGN"
    ],
    "related_stocks": [
        "MRNA",
        "REGN",
        "VRTX",
        "CELG"
    ]
}